Teva Stock Plunges 5.22 as Healthcare Sector Woes Send It 468th in Trading Volume
. 15, , ranking 468th in market activity for the day. The selloff coincided with a broader sector-wide underperformance in healthcare stocks, driven by renewed regulatory scrutiny over drug pricing policies and potential budgetary constraints in key markets.
Analysts highlighted a shift in investor sentiment toward risk-off strategies amid macroeconomic uncertainty. Short-term positioning adjustments by institutional investors, particularly in high-liquidity at-the-money options contracts, amplified volatility. No direct company-specific catalysts were identified in the reporting period, with the decline attributed to systemic market forces rather than operational or strategic developments at Teva.
To run this back-test accurately we need to make a few implementation choices that aren’t fully specified yet. Please let me know (or confirm the defaults I suggest below) so I can set the test up correctly: 1. Universe • Do we screen the entire U.S. listed equity universe (NYSE + NASDAQ + Arca), or a sub-set such as the Russell 3000 constituents? • ADRs, ETFs and preferred shares – include or exclude? 2. Ranking & rebalancing frequency • “Top 500 by daily trading volume” – confirm we rank each trading day’s dollar volume (shares × price) and form the portfolio after the close of that same day. • Rebalance daily; positions are held for exactly one trading day (bought at today’s close, sold at tomorrow’s close). Correct? 3. Weighting method • Equal-weight each of the 500 names (typical in academic volume-based studies). • Or value-weight by today’s market cap? 4. Trading assumptions • Price used for entry/exit: closing price. • Transaction cost/slippage: assume zero, or specify per side (e.g., 5 bp)? 5. Survivorship bias • OK to use the current live universe (which introduces survivorship bias) or should we use a survivorship-free dataset (slower to run)? Once these points are fixed I’ll generate the data-retrieval plan and run the back-test.

Hunt down the stocks with explosive trading volume.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet